ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

The American Cancer Society released updated guidelines for colorectal cancer screening, adding options for a blood-based ...

May 27 (Reuters) - People who skip colorectal cancer screening because colonoscopy or stool testing seems too burdensome now have a blood test option from Guardant Health among recommendations ‌by the ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the nationwide ...

A groundbreaking blood test for colorectal cancer screening has received approval from the U.S. Food and Drug Administration (FDA), offering the potential to revolutionize early detection for one of ...

A new test could be an option for the 40% of Americans over age 45 who are not up to date with screenings. The Food and Drug Administration provided final approval on Monday for a new colorectal ...

For the first time, a blood test has been added to the list of the American Cancer Society's recommended screenings for colorectal cancer. It's not meant to replace colonoscopies, aiming instead at ...

Natera recently announced that its Signatera minimal residual disease (MRD) test received approval from Japan’s Pharmaceuticals and Medical Devices Agency for use in colorectal cancer patients in the ...

A major European trial has pushed colonoscopy back into the medical spotlight. After 13 years, the NordICC study found that ...

An investigational blood test for early detection of colorectal cancer (CRC) in average-risk adults met the primary endpoints of sensitivity and specificity in the PREEMPT CRC study, the largest study ...